These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29860174)

  • 1. The antimalarial pipeline.
    Hooft van Huijsduijnen R; Wells TN
    Curr Opin Pharmacol; 2018 Oct; 42():1-6. PubMed ID: 29860174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovering and developing new medicines for malaria control and elimination.
    Wells TN
    Infect Disord Drug Targets; 2013 Aug; 13(4):292-302. PubMed ID: 24304355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review on diverse heterocyclic compounds as the privileged scaffolds in antimalarial drug discovery.
    Kalaria PN; Karad SC; Raval DK
    Eur J Med Chem; 2018 Oct; 158():917-936. PubMed ID: 30261467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria medicines: a glass half full?
    Wells TN; Hooft van Huijsduijnen R; Van Voorhis WC
    Nat Rev Drug Discov; 2015 Jun; 14(6):424-42. PubMed ID: 26000721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38.
    Armstrong JF; Campo B; Alexander SPH; Arendse LB; Cheng X; Davenport AP; Faccenda E; Fidock DA; Godinez-Macias KP; Harding SD; Kato N; Lee MCS; Luth MR; Mazitschek R; Mittal N; Niles JC; Okombo J; Ottilie S; Pasaje CFA; Probst AS; Rawat M; Rocamora F; Sakata-Kato T; Southan C; Spedding M; Tye MA; Yang T; Zhao N; Davies JA
    Br J Pharmacol; 2023 Aug; 180(15):1899-1929. PubMed ID: 37197802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multistage inhibitors of the malaria parasite: Emerging hope for chemoprotection and malaria eradication.
    Poonam ; Gupta Y; Gupta N; Singh S; Wu L; Chhikara BS; Rawat M; Rathi B
    Med Res Rev; 2018 Sep; 38(5):1511-1535. PubMed ID: 29372568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efforts Aimed To Reduce Attrition in Antimalarial Drug Discovery: A Systematic Evaluation of the Current Antimalarial Targets Portfolio.
    Chaparro MJ; Calderón F; Castañeda P; Fernández-Alvaro E; Gabarró R; Gamo FJ; Gómez-Lorenzo MG; Martín J; Fernández E
    ACS Infect Dis; 2018 Apr; 4(4):568-576. PubMed ID: 29320160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to antimalarial drug discovery.
    Biot C; Chibale K
    Infect Disord Drug Targets; 2006 Jun; 6(2):173-204. PubMed ID: 16789878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.
    Okombo J; Chibale K
    Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing the next generation of medicines for malaria control and eradication.
    Burrows JN; van Huijsduijnen RH; Möhrle JJ; Oeuvray C; Wells TN
    Malar J; 2013 Jun; 12():187. PubMed ID: 23742293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic Screens in Antimalarial Drug Discovery.
    Hovlid ML; Winzeler EA
    Trends Parasitol; 2016 Sep; 32(9):697-707. PubMed ID: 27247245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hits, leads and drugs against malaria through diversity-oriented synthesis.
    Dandapani S; Comer E; Duvall JR; Munoz B
    Future Med Chem; 2012 Dec; 4(18):2279-94. PubMed ID: 23234551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinoline-based antimalarial hybrid compounds.
    Vandekerckhove S; D'hooghe M
    Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From hybrid compounds to targeted drug delivery in antimalarial therapy.
    Oliveira R; Miranda D; Magalhães J; Capela R; Perry MJ; O'Neill PM; Moreira R; Lopes F
    Bioorg Med Chem; 2015 Aug; 23(16):5120-30. PubMed ID: 25913864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
    Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
    PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resisting resistance: is there a solution for malaria?
    Verlinden BK; Louw A; Birkholtz LM
    Expert Opin Drug Discov; 2016; 11(4):395-406. PubMed ID: 26926843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feeding the antimalarial pipeline.
    Schlitzer M; Ortmann R
    ChemMedChem; 2010 Nov; 5(11):1837-40. PubMed ID: 20922746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.